查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942351

透析市場規模、佔有率、趨勢及預測（按類型、產品類型、服務、最終用戶和地區分類），2026-2034年

Dialysis Market Size, Share, Trends and Forecast by Type, Product and Services, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球透析市場規模為1,258億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到1,812億美元，2026年至2034年的複合年成長率（CAGR）為4.14%。截至2025年，北美市場佔據主導地位，市佔率達41.0%。推動市場成長的主要因素包括：慢性腎臟病和末期腎功能衰竭盛行率不斷上升、糖尿病和高血壓病例增加、透析設備技術進步、醫療費用支出不斷成長、家庭透析解決方案的廣泛應用、有利的政府政策、報銷機制以及全球人口老化。

全球市場的主要驅動力是慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 盛行率的不斷上升。根據行業報告顯示，65 歲及以上人口的比例預計將從 2024 年的 10% 成長到 2050 年的 16% 以上。如果 1990 年至 2016 年的趨勢持續下去，到 2050 年，許多地區 3 至 5 級 CKD 的盛行率可能超過 10%，這主要是由於糖尿病和高血壓的增加，而糖尿病和高血壓是慢性腎臟病疾病的主要危險因子。老年人口的成長以及已開發國家和開發中國家醫療費用支出的增加正在推動市場成長。此外，透析設備和治療技術的不斷進步以及人們對腎臟健康的意識提升也是推動市場成長的因素。同時，政府的積極措施、報銷政策以及家庭透析解決方案的廣泛應用也提升了市場的吸引力。

美國作為重要的區域市場脫穎而出，其主要驅動力是慢性腎臟病(CKD) 和末期腎功能衰竭(ESRD) 患病率的上升，而這主要是由於糖尿病和高血壓病例的增加。反過來，這又因老齡化族群腎病風險的增加而推動了市場需求。此外，透析設備的技術創新，例如改進的過濾方法、提高材料的生物相容性、更精確的監測系統、用於個人化治療的自動化以及與遠端醫療的整合，都使患者就醫更加便捷，並推動了市場發展。例如，費森尤斯於2024年12月6日宣布計劃於2025年在美國實現其廣泛應用的血液透析濾過 (HDF) 技術的商業化，並強調該技術有望透過改善對流清除率和降低住院率來改善患者預後。在2024年腎臟週上，費森尤斯重點展示了其5008X透析機。該設備無需對供水系統進行大規模維修即可實現門診血液透析濾過（HDF），研究表明，與標準血液透析相比，HDF在降低死亡率、改善貧血和提高生活品質方面均有顯著優勢。此外，聯邦醫療保險（Medicare）和聯邦醫療補助（Medicaid）的優惠報銷政策也大大促進了病患獲得治療的機會。同時，大型透析服務供應商的存在也推動了美國透析市場的擴張。

透析市場趨勢：

生活方式的改變日益頻繁，導致腎臟併發症。

生活方式的改變正在推動市場發展。根據美國國立衛生研究院 (NIH) 統計，慢性腎臟病(CKD) 影響著超過七分之一的美國成年人，估計影響著 3,550 萬美國人，凸顯了其日益嚴重的公共衛生問題。不健康的飲食習慣，例如過度食用加工食品、高鹽飲食和水分攝取不足，會導致高血壓和糖尿病等慢性疾病，而這些疾病正是腎臟疾病的主要誘因。生活方式因素與腎臟併發症之間的關聯性正在加劇慢性腎臟病的盛行率。腎臟相關疾病的增加推動了透析治療的需求，因為患者需要腎臟替代療法來維持生活品質。患者數量的不斷成長使得擴大透析服務勢在必行，進一步推動了市場發展。此外，醫療保健機構、醫療設備製造商和研究人員的持續創新正在促進解決方案和策略的開發，以滿足不斷成長的需求並提供有效的透析干預措施，從而進一步促進市場發展。

私人透析診所和中心的擴張

私人透析診所和中心的興起，憑藉其諸多關鍵優勢，正在推動市場擴張。根據美國國家醫學圖書館統計，印度約有950名腎臟科醫師和700多家透析中心（配備4,000多台透析機），其中大部分為私人機構，且主要集中在大都會圈。透析需求的不斷成長正推動著私人透析機構在全國範圍內的擴張。私人診所通常提供針對每位患者獨特需求的專業化、個人化照護。這種客製化護理能夠提高患者滿意度和治療效果，從而吸引更多患者，並增強市場需求。此外，私人透析中心提供更靈活的預約安排，充分考慮患者的便利性和日常生活習慣。這種便利性吸引了那些希望在忙碌生活中尋求合適治療方案的患者。同時，私人診所的建立也促進了市場內的良性競爭。這種競爭鼓勵治療方法的創新、技術的應用以及病患服務的改進，最終提升整個產業的醫療品質。此外，私立透析中心通常配備最新的透析設備和技術，以及技術精湛的醫護人員，確保高效優質的治療。這種高標準的護理有助於建立患者和轉診醫生之間的信任，從而促進更多患者轉診和市場成長。私立透析中心為尋求透析服務的患者提供了另一種選擇，有助於減輕公共醫療系統的負擔。這在公共資源有限的地區尤其重要，因為私人透析中心可以減輕醫療基礎設施的壓力。

對改良型腹膜透析技術的需求日益成長

持續性攜帶式腹膜透析 (CAPD) 和自動化腹膜透析 (APD) 的需求不斷成長，推動了市場發展。根據通報，在美國，夜間自動化腹膜透析 (APD) 的使用率正在上升，佔新腹膜透析 (PD) 患者的 86%，這標誌著治療方法正顯著朝向更先進的方向發展。這些先進的腹膜透析技術因其諸多優勢而日益普及。與傳統的中心血液透析相比，CAPD 和 APD 為患者提供了更靈活、更方便的治療選擇。 CAPD 讓患者在白天手動更換透析液，即使在接受治療的同時，也能更自由地進行日常活動。 APD 更進一步，讓機器能夠在夜間自動完成透析液更換，讓患者在睡眠中也能接受治療。 CAPD 和 APD 持續穩定的毒素清除能力，能夠穩定血液化學成分並改善整體健康狀況，從而推動了市場需求的成長。這些技術還能盡量減少患者頻繁前往透析中心的次數，進而減少對患者日常生活的干擾。此外，CAPD 和 APD 非常適合居家照護，符合個人化醫療和遠端監測日益成長的趨勢。患者可以接受訓練在家中進行這些操作，從而增強他們對自身治療的掌控感和自主性。隨著患者和醫療服務提供者對 CAPD 和 APD 益處的認知不斷加深，預計對這些技術的需求將會增加。這反過來又推動了腹膜透析技術的進一步研究和創新，以及針對選擇這些方法的患者提供的培訓項目和支援服務的擴展，從而促進了市場成長。

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 調查方法

第3章執行摘要

第4章 引言

第5章 全球透析市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 按類型分類的市場區隔

  • 血液透析
    • 主要部分
      • 傳統血液透析
      • 短期門診血液透析
      • 夜間血液透析
  • 腹膜透析
    • 主要部分
      • 持續性攜帶式腹膜透析（CAPD）
      • 自動腹膜透析（APD）

第7章 按產品和服務分類的市場細分

  • 服務
  • 裝置
    • 主要部分
      • 透析機
      • 水處理系統
      • 其他
  • 消耗品
    • 主要部分
      • 透析器
      • 導管
      • 其他
  • 透析藥物

第8章 按最終用戶分類的市場細分

  • 中心透析
  • 居家透析

第9章 按地區分類的市場細分

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章 價值鏈分析

第12章 波特五力分析

第13章：定價分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Asahi Kasei Medical Co., Ltd.
    • B. Braun Medical Inc.
    • Becton, Dickinson and Company
    • DaVita Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • JMS Co. Ltd.
    • Nikkiso Co. Ltd.
    • NIPRO Corporation
    • Satellite Healthcare Inc.
    • Teleflex Incorporated
    • Toray Medical Co., Ltd.
    • Vantive Health LLC（Baxter International Inc）
Product Code: SR112026A5940

The global dialysis market size was valued at USD 125.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 181.2 Billion by 2034, exhibiting a CAGR of 4.14% during 2026-2034. North America currently dominates the market in 2025, accounting to 41.0% of the market share. The major drivers of the market include the increasing prevalence of chronic kidney disease and end-stage renal disease, rising diabetes and hypertension cases, technological advancements in dialysis equipment, growing healthcare spending, expanding home dialysis solutions, favorable government policies, reimbursement initiatives, and an aging global population.

The global market is majorly driven by the increasing prevalence of chronic kidney disease and end-stage renal disease. As per industry reports, the proportion of individuals aged 65 years or older is projected to increase from 10% in 2024 to over 16% by 2050. If trends from 1990 to 2016 continue, the prevalence of CKD in categories G3-G5 will likely exceed 10% in many regions by 2050, mainly due to rising rates of diabetes and hypertension, which are key risk factors for kidney disorders. This increase in geriatric population, along with increased healthcare spend in developed and developing economies is providing a boost to the market growth. Additionally, ongoing technological advancements in dialysis equipment and procedures and awareness about renal health is propelling the market. Apart from this, favorable government initiatives, reimbursement policies, and availability of home dialysis solutions are stimulating the market appeal.

The United States stands out as a key regional market, and is primarily driven by the growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), mainly due to increasing cases of diabetes and hypertension. In line with this, growing demographics with a higher inclination towards age-related kidney issues is increasing the demand further. Furthermore, ongoing technological advancements in dialysis machines, such as improved filtration methods, better biocompatibility of materials, more precise monitoring systems, and automation for personalized treatment, and telehealth integration is making the process more convenient for patients, thereby supporting the market. For instance, on December 6, 2024, Fresenius announced plans for a broad U.S. commercial launch of hemodiafiltration (HDF) technology in 2025, emphasizing its potential to improve patient outcomes through increased convective clearance and reduced hospitalizations. During Kidney Week 2024, Fresenius highlighted its 5008X dialysis machine, which enables outpatient HDF without significant water system retrofitting, and showcased studies demonstrating HDF's benefits in mortality, anemia, and quality of life compared to standard hemodialysis. Besides this, favorable reimbursement policies by Medicare and Medicaid significantly support accessibility to treatment. Moreover, the presence of major dialysis service providers, is contributing to the expansion of the dialysis market in the U.S.

Dialysis Market Trends:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market.. According to National Institutes of Health, chronic kidney disease (CKD) affects over 1 in 7 U.S. adults, impacting an estimated 35.5 million Americans, highlighting a growing public health concern. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further propelling the market. Apart from this, ongoing innovations by healthcare providers, medical device manufacturers, and researchers to develop solutions and strategies to address this growing demand and offer effective dialysis interventions, is fostering the market further.

Expansion of private dialysis clinics and centers

The rise in the number of private dialysis clinics and centers that offer several key advantages contribute to the impact on market expansion. According to National Library of Medicine, India has nearly 950 nephrologists and over 700 dialysis centers with 4,000 machines, predominantly in the private sector, largely concentrated in metros. The growing demand for dialysis is driving the expansion of private facilities across the country. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization improves patient satisfaction and outcomes, attracting a larger clientele and strengthening the market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for Improved Peritoneal Dialysis Techniques

The escalating demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) is fueling the market growth. According to reports, nocturnal automated peritoneal dialysis (APD) usage rising in the United States, now comprises 86% of patients on incident peritoneal dialysis (PD), reflecting a significant shift towards more advanced treatment options. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, is fueling market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

Analysis by Type:

  • Hemodialysis
    • Conventional Hemodialysis
    • Short Daily Hemodialysis
    • Nocturnal Hemodialysis
  • Peritoneal Dialysis
    • Continuous Ambulatory Peritoneal Dialysis (CAPD)
    • Automated Peritoneal Dialysis (APD)

Hemodialysis stands as the largest component in 2025, accounting to 97.6% of the market share. Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses crucial medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology improved treatment outcomes and patient experiences. Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Analysis by Product and Services:

  • Services
  • Equipment
    • Dialysis Machines
    • Water Treatment Systems
    • Others
  • Consumables
    • Dialyzers
    • Catheters
    • Others
  • Dialysis Drugs

Services lead the market in 2025, accounting to 79.0% of the market share. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues, which is another factor contributing to the growth of this segment.

Analysis by End User:

  • In-center Dialysis
  • Home Dialysis

In- center dialysis leads the market in 2025. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges. The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Moreover, in-center dialysis provides patients with structured environment, professional support, and regular check-ins. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 41.0%. With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development (R&D) fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies. Supportive government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, augmenting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Key Regional Takeaways:

United States Dialysis Market Analysis

In 2025, the United States accounted for 87.80% of the North America dialysis market. The increasing focus on the betterment of healthcare systems led to considerable financial inputs aimed at improving access to life-saving treatments. Reports indicate that in 2023, the U.S. spent USD 4.9 Trillion on healthcare, where 60% of the total expenditure was comprised of hospital care, physician and clinical services, and retail prescription drugs. This trend has had significant beneficial effects on the services regarding dialysis. Also, efforts made to increase advanced treatment centers, modernization of machinery, and furthering specialty training for medical professionals have increased in uptake. Policies with an ultimate goal of improved patient-care outcomes have been fast movers in creating innovations specifically intended to suit needs in providing regular renal support to persons. The availability of funding has facilitated the establishment of numerous treatment centers, reduced patient travel time and improving accessibility. Furthermore, initiatives to promote awareness about chronic kidney conditions and their management have encouraged earlier intervention and greater reliance on these life-sustaining therapies. The integration of advanced technology to support better patient monitoring and efficient workflows further propelled adoption rates, making it a critical component of healthcare improvement strategies.

Asia Pacific Dialysis Market Analysis

With the increasing rise of kidney-related illnesses, the trend of adopting dialysis at most health care centers has also emerged. Thereby, notably, the instances of kidney failure, at nearly 210,000 new cases every year, call for an immediate requirement for dialysis adoption-an approach that saves lives by being a lifesaving means for the effective management of chronic conditions. An accelerating awareness of advanced treatment facilities and better access to health care encouraged patients to take dialysis as a necessary solution for chronic illnesses. Moreover, the escalating lifestyle diseases such as hypertension and diabetes have significantly increased the risk of diseases for kidneys, which in turn is creating further demand for dialysis. Furthermore, ongoing technological advancements in equipment and techniques of dialysis are also contributing to an increased acceptance rate as a result of improved comfort along with effectiveness. Urbanization and changes in the existing healthcare infrastructure have made dialysis accessible to larger populations even in areas where awareness remained limited. Additionally, government favorable initiatives and educational campaigns are also assisting in early diagnosis and subsequent timely intervention, thereby highlighting the role of dialysis in prolonging life expectancy and improving patient outcomes. The number of individuals requiring dialysis continues to increase steadily, due to an aging population with a growing burden of chronic diseases.

Europe Dialysis Market Analysis

The increasing number of home-based treatments has improved the care delivery system as it offers more convenience and independence to the patients. For instance, home dialysis in the UK is in rapid increase with more than 25,000 currently undergoing treatment. Hemodialysis cases increased by 10%. Flexibility in their treatment schedules enables people to integrate therapy into their day-to-day activities, improve adherence, and satisfaction. This model reduces dependence on in-clinic visits. Thereby, it reduces the pressure on healthcare infrastructure and will enable providers to focus on resource-intensive cases. Portable equipment, combined with tailored support services has made home-based options accessible and effective. Remote monitoring and virtual consultations have ensured consistent oversight by healthcare professionals, addressing patient concerns promptly. Training programs for patients and caregivers further strengthen the feasibility of administering therapies outside traditional settings. Such developments have reinforced adoption, particularly among those seeking greater control over their healthcare journey. These trends highlight the growing importance of personalized, patient-centric solutions in addressing chronic kidney conditions.

Latin America Dialysis Market Analysis

Expanding private sector involvement increased the adoption of advanced medical treatments by fostering innovation and competition. According to International Trade Administration, Brazil, the largest healthcare market in Latin America, spends 9.47% of its GDP (USD161 Billion) on healthcare, with 62% of its 7,191 hospitals being private. High-quality dialysis services are becoming increasingly accessible due to investments in modern facilities and advanced technologies. Private healthcare providers prioritize efficient service delivery and patient satisfaction, which resulted in streamlined processes and tailored treatment plans. Improved infrastructure supports specialized centers catering to renal conditions, reducing waiting times and improving outcomes. Public-private collaborations have also contributed to improving accessibility for a broader demographic, addressing the rising demand for reliable and effective therapies. This dynamic growth has positioned renal treatments as a key area for ongoing improvement and patient-centered care.

Middle East and Africa Dialysis Market Analysis

Expanding infrastructure has been pivotal in improving access to essential medical services. According to Dubai Healthcare City Authority report, by 2022, Dubai had 4,482 private medical facilities, including 56 hospitals, and 55,208 licensed professionals. With projected growth of 10-15% in medical professionals and 3-6% in facilities, the expanding healthcare sector will improve dialysis care accessibility. Newly developed treatment centers and improved diagnostic capabilities have played a crucial role in addressing the growing prevalence of renal conditions. These developments have ensured that therapies are more widely available, even in remote areas. Investment in workforce development has improved the expertise of medical professionals, ensuring high-quality care delivery. Community outreach programs have raised awareness about chronic kidney conditions and the importance of early intervention, encouraging increased reliance on advanced therapies. The incorporation of innovative solutions to improve treatment efficiency has further propelled the adoption of dialysis as a critical healthcare service.

Competitive Landscape:

The dialysis market is very competitive, with numerous healthcare providers, equipment manufacturers, and service operators. The market is technologically driven, with companies trying to innovate in developing dialysis machines, home dialysis solutions, and integrated care models. High demand for personalized treatment and cost-effective therapies resulted in massive investments in research and development (R&D). Expanding infrastructures of healthcare, government support, and effective reimbursement policies are also accelerating market competition. Providers' differentiation is also done through service quality, patient outcome, and strategic partnerships for expanding market share and to meet the increasing flow of patients.

The report provides a comprehensive analysis of the competitive landscape in the dialysis market with detailed profiles of all major companies, including:

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Medical Inc.
  • Becton, Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Teleflex Incorporated
  • Toray Medical Co., Ltd.
  • Vantive Health LLC (Baxter International Inc)

Key Questions Answered in This Report

  • 1.How big is the dialysis market?
  • 2.What is the future outlook of the dialysis market?
  • 3.What are the key factors driving the dialysis market?
  • 4.Which region accounts for the largest dialysis market share?
  • 5.Which are the leading companies in the global dialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemodialysis
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Conventional Hemodialysis
      • 6.1.2.2 Short Daily Hemodialysis
      • 6.1.2.3 Nocturnal Hemodialysis
    • 6.1.3 Market Forecast
  • 6.2 Peritoneal Dialysis
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • 6.2.2.2 Automated Peritoneal Dialysis (APD)
    • 6.2.3 Market Forecast

7 Market Breakup by Product and Services

  • 7.1 Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Equipment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Dialysis Machines
      • 7.2.2.2 Water Treatment Systems
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast
  • 7.3 Consumables
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Dialyzers
      • 7.3.2.2 Catheters
      • 7.3.2.3 Others
    • 7.3.3 Market Forecast
  • 7.4 Dialysis Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 In-center Dialysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Dialysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Asahi Kasei Medical Co., Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Medical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Becton, Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 DaVita Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Fresenius Medical Care AG & Co. KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 JMS Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Nikkiso Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 NIPRO Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Satellite Healthcare Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Teleflex Incorporated
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Toray Medical Co., Ltd.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vantive Health LLC (Baxter International Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Dialysis Market: Major Drivers and Challenges
  • Figure 2: Global: Dialysis Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Dialysis Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Dialysis Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Dialysis Market: Breakup by Product and Services (in %), 2025
  • Figure 6: Global: Dialysis Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Dialysis Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Dialysis (Hemodialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Dialysis (Hemodialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Dialysis (Peritoneal Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Dialysis (Peritoneal Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Dialysis (Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Dialysis (Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Dialysis (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Dialysis (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Dialysis (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Dialysis (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Dialysis (Dialysis Drugs) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Dialysis (Dialysis Drugs) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Dialysis (In-center Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Dialysis (In-center Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Dialysis (Home Dialysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Dialysis (Home Dialysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: United States: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: United States: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Canada: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Canada: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Asia-Pacific: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Asia-Pacific: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: China: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: China: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Japan: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Japan: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: India: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: India: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: South Korea: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: South Korea: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Australia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Australia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Indonesia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Indonesia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Europe: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Europe: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Germany: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Germany: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: France: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: France: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: United Kingdom: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: United Kingdom: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Italy: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Italy: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Spain: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Spain: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Russia: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Russia: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Latin America: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Latin America: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Brazil: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Brazil: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Mexico: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Mexico: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Middle East and Africa: Dialysis Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Middle East and Africa: Dialysis Market: Breakup by Country (in %), 2025
  • Figure 72: Middle East and Africa: Dialysis Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Global: Dialysis Industry: SWOT Analysis
  • Figure 74: Global: Dialysis Industry: Value Chain Analysis
  • Figure 75: Global: Dialysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dialysis Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Dialysis Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Dialysis Market Forecast: Breakup by Product and Services (in Million USD), 2026-2034
  • Table 4: Global: Dialysis Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Dialysis Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Dialysis Market: Competitive Structure
  • Table 7: Global: Dialysis Market: Key Players